Early Access — free while we kick the tires
EdgarHawk

Arno Andrew

Director

Director
1 filing analyzed · 1 company · Latest 2024-12-26

Companies

Company Buys Sells Direction
Oncocyte Corp IMDX 1 0 Net buying

Activity

December 2024
2024-12-26 Oncocyte Corp IMDX
medium
Buy
12,500 shares
$26,350
Significance 4/10

Director Arno Andrew purchases 12,500 shares of OCX at $2.11 on 2024-12-26, bringing holdings to 81,554 shares (+18.1%).

Arno Andrew, a Director, acquired 12,500 shares at $2.11 on 2024-12-26, increasing his holdings by 18.1% from 69,054 to 81,554 shares. The transaction occurs as OCX trades 40.8% below its 52-week high of $3.60 and has declined 26.0% over 90 days, suggesting the purchase comes during a period of stock weakness. While Andrew's cross-ticker track record across 2 prior buys shows a 100.00% 90-day win rate with average 90d return of +394116589.3%, his single prior trade at OCX on 2024-04-11 delivered a +2.4% 90-day return, providing limited evidence of accurate timing at this specific ticker. The company is materially unprofitable with net income of $-13,493,000.00 against revenue of $115,000.00 in the latest quarter, though it has achieved +56.9% annual revenue growth, creating an uncertain fundamental backdrop against which to evaluate this purchase.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access